For these reasons, a cell-penetrating peptide, designated GO-203, has been developed that targets the MUC1-C CQC motif, inhibits MUC1-C homodimerization, nuclear import and function, and is effective in inducing MM cell death [6-8]. This evidence concerns the gene MUC1 and Miyoshi myopathy.